BESPONSA

Formula & Concentration

BESPONSA – inotuzumab ozogamicin 0.9 MG(0.25 MG/ML initial concentration) IV soln

Manufacturer

Pfizer Inc.

Indications

BESPONSA – inotuzumab ozogamicin 0.9 MG(0.25 MG/ML initial concentration) IV soln

Product Options

Package Size

NDC #

Presentation

0.9 MG

00008-0100-01

POWDER

Shelf Life and Storage

Fridge (2-8°C)